ADEFOVIR DIPIVOXIL

ADEFOVIR DIPIVOXIL was reported 1271 times

ADEFOVIR DIPIVOXIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ONCOGENIC OSTEOMALACIA 4 0.5714
1 ASYMPTOMATIC VIRAL HEPATITIS 3 0.4286
2 HIV LIPODYSTROPHY 3 0.3000
3 HEPATITIS B DNA DECREASED 2 0.2500
4 URINE LACTIC ACID INCREASED 1 0.2500
5 HYPOPHOSPHATAEMIC OSTEOMALACIA 59 0.2235
6 URINE PHOSPHORUS DECREASED 8 0.1860
7 ELECTROCARDIOGRAM P PULMONALE 2 0.1818
8 OSTEOMALACIA 224 0.1449
9 HYPERSPLENISM ACQUIRED 1 0.1429
10 ALPHA 1 MICROGLOBULIN INCREASED 3 0.1429
11 URINE PHOSPHORUS INCREASED 14 0.1284
12 BETA 2 MICROGLOBULIN URINE ABNORMAL 1 0.1250
13 FRACTIONAL EXCRETION OF PHOSPHATE 1 0.1250
14 URINE URIC ACID DECREASED 1 0.1111
15 LACTATE DEHYDROGENASE URINE INCREASED 1 0.1111
16 HYPOURICAEMIA 21 0.0724
17 HEPATITIS B E ANTIGEN POSITIVE 3 0.0714
18 HYPERPHOSPHATURIA 8 0.0684
19 GASTROLITHIASIS 2 0.0667
20 PROTEIN URINE ABSENT 1 0.0625
21 RENAL GLYCOSURIA 4 0.0588
22 FANCONI SYNDROME ACQUIRED 101 0.0575
23 FANCONI SYNDROME 79 0.0558
24 HEPATITIS B DNA INCREASED 36 0.0534
25 PSEUDOFRACTURE 1 0.0526
26 OSTEOCALCIN INCREASED 2 0.0488
27 ACQUIRED AMINOACIDURIA 2 0.0488
28 OSTEODYSTROPHY 2 0.0455
29 RENAL TUBULAR DYSFUNCTION 25 0.0442
30 GENOTYPE DRUG RESISTANCE TEST POSITIVE 41 0.0399
31 HEPATITIS B DNA ASSAY POSITIVE 5 0.0391
32 PERIHEPATIC DISCOMFORT 3 0.0345
33 VIRAL MUTATION IDENTIFIED 123 0.0334
34 TRANSAMINASES DECREASED 2 0.0294
35 TRANSCATHETER ARTERIAL CHEMOEMBOLISATION 1 0.0286
36 OSTEOCALCIN DECREASED 1 0.0286
37 URINE ANALYSIS 1 0.0286
38 SPIDER NAEVUS 5 0.0270
39 CONGENITAL KNEE DISLOCATION 1 0.0250
40 BLOOD 1,25-DIHYDROXYCHOLECALCIFEROL DECREASED 2 0.0247
41 GENITOURINARY TRACT NEOPLASM 2 0.0241
42 URINE POTASSIUM INCREASED 2 0.0230
43 EPIPHYSEAL DISORDER 1 0.0222
44 HYPOPHOSPHATAEMIA 163 0.0220
45 VIRAL LOAD DECREASED 3 0.0205
46 GENOTYPE DRUG RESISTANCE TEST 1 0.0204
47 VIRAL LOAD INCREASED 77 0.0198
48 PHOSPHORUS METABOLISM DISORDER 1 0.0196
49 BETA-N-ACETYL-D-GLUCOSAMINIDASE INCREASED 1 0.0192
50 AMINOACIDURIA 3 0.0189
51 HYPERPHOSPHATASAEMIA 2 0.0182
52 PENICILLIUM INFECTION 3 0.0167
53 PATHOGEN RESISTANCE 152 0.0167
54 BONE METABOLISM DISORDER 5 0.0166
55 BLOOD URIC ACID DECREASED 8 0.0165
56 MULTIPLE-DRUG RESISTANCE 51 0.0164
57 HBV DNA INCREASED 1 0.0164
58 URINE CALCIUM INCREASED 5 0.0159
59 BLOOD PHOSPHORUS DECREASED 58 0.0159
60 PROSTATIC CALCIFICATION 2 0.0156
61 GLYCOSURIA 20 0.0148
62 URINE CALCIUM DECREASED 1 0.0137
63 HEPATITIS B REACTIVATION 43 0.0135
64 BONE MARROW OEDEMA 14 0.0135
65 RENAL TUBULAR DISORDER 34 0.0121
66 HEPATITIS D 1 0.0119
67 PH URINE INCREASED 2 0.0116
68 GLUCOSE URINE PRESENT 14 0.0110
69 HEPATITIS B SURFACE ANTIGEN POSITIVE 3 0.0109
70 DRUG RESISTANCE 275 0.0107
71 BLOOD PHOSPHORUS ABNORMAL 5 0.0106
72 BURKHOLDERIA CEPACIA COMPLEX INFECTION 3 0.0105
73 GALLBLADDER OEDEMA 3 0.0102
74 HEPATIC NEOPLASM MALIGNANT RECURRENT 1 0.0094
75 BONE SCAN ABNORMAL 4 0.0094
76 MYOGLOBINAEMIA 1 0.0085
77 ACQUIRED EPIDERMOLYSIS BULLOSA 1 0.0081
78 HEPATITIS B CORE ANTIBODY POSITIVE 3 0.0080
79 ALBUMIN URINE PRESENT 3 0.0079
80 HEPATITIS B 47 0.0078
81 RENAL SALT-WASTING SYNDROME 3 0.0077
82 PARVOVIRUS INFECTION 3 0.0074
83 BETA 2 MICROGLOBULIN URINE INCREASED 1 0.0070
84 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 2 0.0069
85 GLUCOSE URINE 1 0.0067
86 HYPERPHOSPHATAEMIA 14 0.0065
87 RENAL TUBULAR ACIDOSIS 14 0.0064
88 HYDROTHORAX 5 0.0060
89 COUNTERFEIT DRUG ADMINISTERED 2 0.0058
90 INTERCOSTAL NEURALGIA 1 0.0056
91 GENE MUTATION 11 0.0056
92 PRESBYOPIA 3 0.0054
93 DEXTROCARDIA 1 0.0053
94 HEPATITIS B ANTIBODY POSITIVE 1 0.0053
95 BENIGN PANCREATIC NEOPLASM 1 0.0053
96 BONE DENSITY INCREASED 2 0.0050
97 BONE FORMATION INCREASED 1 0.0049
98 IMPLANTATION COMPLICATION 1 0.0048
99 SUSPECTED COUNTERFEIT PRODUCT 19 0.0048
100 ACUTE ON CHRONIC LIVER FAILURE 1 0.0046
101 MUSCLE ENZYME INCREASED 2 0.0045
102 HEPATOCELLULAR CARCINOMA 34 0.0045
103 HEPATIC ATROPHY 2 0.0045
104 PROTEIN URINE 4 0.0044
105 GASTRIC VARICES 2 0.0042
106 HYPERCALCIURIA 2 0.0041
107 METASTASES TO ABDOMINAL CAVITY 2 0.0041
108 CHRONIC GASTROINTESTINAL BLEEDING 1 0.0039
109 SHORT STATURE 1 0.0038
110 MYOGLOBINURIA 2 0.0038
111 OSTEOPOROSIS 154 0.0037
112 LOWER RESPIRATORY TRACT INFLAMMATION 1 0.0037
113 BLEEDING VARICOSE VEIN 2 0.0037
114 POIKILOCYTOSIS 1 0.0036
115 HEPATIC CANCER RECURRENT 1 0.0035
116 HAEMORRHAGIC ASCITES 1 0.0035
117 KYPHOSIS 6 0.0034
118 DOUBLE OUTLET RIGHT VENTRICLE 1 0.0034
119 FIBRIN DEGRADATION PRODUCTS INCREASED 1 0.0034
120 HYPERPLASIA 3 0.0033
121 FEMORAL NECK FRACTURE 17 0.0033
122 NEPHROPATHY TOXIC 37 0.0033
123 RENAL TUBULAR INJURY 4 0.0033
124 FOETAL CARDIAC DISORDER 1 0.0032
125 VARICOSE VEIN RUPTURED 1 0.0031
126 COSTOCHONDRITIS 5 0.0031
127 GASTRIC VARICES HAEMORRHAGE 1 0.0030
128 HEPATORENAL SYNDROME 5 0.0030
129 GRAFT INFECTION 1 0.0029
130 PULMONARY MALFORMATION 1 0.0028
131 PROTEIN URINE PRESENT 14 0.0028
132 GLOBULINS INCREASED 1 0.0027
133 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
134 MICROALBUMINURIA 2 0.0026
135 HEPATITIS B VIRUS TEST POSITIVE 1 0.0026
136 CARBON DIOXIDE DECREASED 3 0.0026
137 AMYOTROPHY 1 0.0026
138 BLOOD ALKALINE PHOSPHATASE INCREASED 64 0.0026
139 BONE LESION 9 0.0025
140 TUMOUR EXCISION 2 0.0025
141 CARDIAC VENTRICULAR DISORDER 1 0.0024
142 PULMONARY CALCIFICATION 1 0.0024
143 IGA NEPHROPATHY 4 0.0024
144 ENZYME LEVEL INCREASED 2 0.0024
145 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 3 0.0023
146 OESOPHAGEAL VARICES HAEMORRHAGE 5 0.0023
147 OESOPHAGEAL HAEMORRHAGE 3 0.0023
148 VIROLOGIC FAILURE 12 0.0022
149 LIVER TRANSPLANT REJECTION 4 0.0022
150 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
151 EPIDERMOLYSIS 1 0.0022
152 HEPATIC CIRRHOSIS 40 0.0021
153 GLOMERULAR FILTRATION RATE ABNORMAL 3 0.0021
154 LIPOATROPHY 2 0.0021
155 HEMIANOPIA 2 0.0020
156 BONE PAIN 118 0.0020
157 PATELLOFEMORAL PAIN SYNDROME 1 0.0019
158 LIGHT CHAIN ANALYSIS INCREASED 2 0.0019
159 RESPIRATORY TRACT INFECTION FUNGAL 1 0.0019
160 BONE CANCER METASTATIC 1 0.0019
161 HYPERMETABOLISM 1 0.0019
162 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
163 FRACTURE PAIN 1 0.0019
164 BLOOD PHOSPHORUS INCREASED 5 0.0018
165 RHEUMATOID FACTOR INCREASED 2 0.0018
166 ENTEROBACTER INFECTION 3 0.0018
167 PRODUCT COUNTERFEIT 3 0.0017
168 GASTROINTESTINAL POLYP HAEMORRHAGE 1 0.0017
169 SOFT TISSUE INFECTION 3 0.0016
170 PROTEINURIA 31 0.0016
171 MYOPATHY TOXIC 1 0.0016
172 FRACTURED SACRUM 2 0.0016
173 HYPERCHLORAEMIA 1 0.0016
174 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
175 ACQUIRED GENE MUTATION 2 0.0015
176 FASCIITIS 1 0.0015
177 ANISOCYTOSIS 1 0.0015
178 SPUTUM ABNORMAL 1 0.0015
179 HEPATIC ENCEPHALOPATHY 14 0.0015
180 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
181 MITRAL VALVE STENOSIS 1 0.0015
182 MARROW HYPERPLASIA 1 0.0015
183 PLEURAL THICKENING 1 0.0015
184 HEPATIC FIBROSIS 5 0.0015
185 HYPERPARATHYROIDISM 3 0.0015
186 VIRAEMIA 2 0.0014
187 DRUG TOLERANCE 7 0.0014
188 MUSCULOSKELETAL CHEST PAIN 21 0.0014
189 BLOOD PARATHYROID HORMONE DECREASED 2 0.0013
190 COMA HEPATIC 1 0.0013
191 AMINO ACID LEVEL INCREASED 1 0.0013
192 MYOGLOBIN BLOOD INCREASED 2 0.0013
193 INTERMITTENT CLAUDICATION 2 0.0013
194 MYOPIA 3 0.0013
195 PULMONARY VALVE STENOSIS 1 0.0013
196 EROSIVE DUODENITIS 1 0.0013
197 ABDOMINAL SYMPTOM 1 0.0012
198 CHRONIC HEPATITIS 1 0.0012
199 HEPATIC FAILURE 37 0.0012
200 BLOOD URIC ACID INCREASED 7 0.0012
201 SYNDACTYLY 1 0.0012
202 GASTRIC DILATATION 2 0.0012
203 FRACTURE DELAYED UNION 1 0.0012
204 SPLEEN DISORDER 2 0.0012
205 HEPATIC CANCER METASTATIC 1 0.0012
206 URINE OUTPUT INCREASED 3 0.0011
207 BONE DENSITY DECREASED 36 0.0011
208 BLOOD ALBUMIN INCREASED 1 0.0011
209 COMPRESSION FRACTURE 6 0.0011
210 MUSCLE NECROSIS 1 0.0011
211 MULTIPLE FRACTURES 18 0.0011
212 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0011
213 NEPHROPATHY 10 0.0011
214 TENDERNESS 11 0.0011
215 WRONG SCHEDULE 1 0.0010
216 PANCREATIC CYST 2 0.0010
217 HYPOREFLEXIA 2 0.0010
218 BLOOD CREATINE PHOSPHOKINASE INCREASED 30 0.0010
219 LUMBAR SPINAL STENOSIS 3 0.0010
220 BONE MARROW DEPRESSION 1 0.0010
221 VARICES OESOPHAGEAL 3 0.0010
222 RIB FRACTURE 20 0.0010
223 GASTROINTESTINAL PERFORATION 4 0.0010
224 BONE DEMINERALISATION 1 0.0009
225 ASTERIXIS 1 0.0009
226 VITAMIN D DECREASED 8 0.0009
227 HAEMORRHAGIC DISORDER 1 0.0009
228 DIABETIC NEPHROPATHY 2 0.0009
229 CHOLESTATIC LIVER INJURY 2 0.0009
230 FACIAL SPASM 1 0.0009
231 CRYPTORCHISM 1 0.0009
232 BLOOD CREATININE ABNORMAL 3 0.0009
233 RENAL FUNCTION TEST ABNORMAL 4 0.0009
234 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
235 SPLENECTOMY 1 0.0009
236 TIBIA FRACTURE 4 0.0009
237 NECROTISING FASCIITIS 3 0.0009
238 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 1 0.0008
239 GLOMERULONEPHRITIS 2 0.0008
240 BLOOD UREA DECREASED 1 0.0008
241 RENAL ATROPHY 1 0.0008
242 TROPONIN T INCREASED 1 0.0008
243 ACIDOSIS 6 0.0008
244 GESTATIONAL HYPERTENSION 1 0.0008
245 LIVER INJURY 19 0.0008
246 ADJUSTMENT DISORDER 1 0.0008
247 EPIGASTRIC DISCOMFORT 3 0.0008
248 PROTEIN TOTAL INCREASED 2 0.0008
249 HYPERLACTACIDAEMIA 2 0.0007
250 POSTPARTUM HAEMORRHAGE 1 0.0007
251 AGORAPHOBIA 1 0.0007
252 ARTHRITIS BACTERIAL 3 0.0007
253 RENAL ARTERY STENOSIS 1 0.0007
254 ASCITES 21 0.0007
255 RENAL IMPAIRMENT 59 0.0007
256 HEPATIC LESION 3 0.0007
257 METABOLIC ACIDOSIS 22 0.0007
258 GENERALISED ANXIETY DISORDER 1 0.0007
259 ANKLE OPERATION 1 0.0007
260 URINE ANALYSIS ABNORMAL 2 0.0007
261 BLOOD CREATININE INCREASED 43 0.0007
262 MARASMUS 1 0.0007
263 PORTAL HYPERTENSION 2 0.0006
264 RENAL INJURY 19 0.0006
265 OSTEOSCLEROSIS 1 0.0006
266 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
267 LIMB DEFORMITY 1 0.0006
268 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
269 TREATMENT FAILURE 51 0.0006
270 RESPIRATORY ALKALOSIS 1 0.0006
271 HEPATIC NEOPLASM 2 0.0006
272 LYMPHOCYTE COUNT INCREASED 2 0.0006
273 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 2 0.0006
274 SPLENOMEGALY 7 0.0006
275 SPINAL PAIN 7 0.0006
276 BLADDER NEOPLASM 1 0.0006
277 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
278 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
279 JOINT EFFUSION 4 0.0006
280 KIDNEY FIBROSIS 1 0.0006
281 HYPERREFLEXIA 2 0.0006
282 ALANINE AMINOTRANSFERASE INCREASED 35 0.0006
283 BLOOD LACTIC ACID INCREASED 3 0.0006
284 CONJUNCTIVAL HYPERAEMIA 2 0.0006
285 LIVER TRANSPLANT 2 0.0005
286 SPONDYLITIS 2 0.0005
287 HEPATIC CANCER 13 0.0005
288 HEPATIC FUNCTION ABNORMAL 20 0.0005
289 BONE DENSITY ABNORMAL 2 0.0005
290 BLOOD CALCIUM DECREASED 6 0.0005
291 FRACTURE 10 0.0005
292 OSTEOPENIA 8 0.0005
293 HYPOPROTEINAEMIA 1 0.0005
294 MYELOPATHY 1 0.0005
295 HEPATIC MASS 1 0.0005
296 RHEUMATIC DISORDER 1 0.0005
297 METABOLIC DISORDER 3 0.0005
298 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
299 VITAMIN D DEFICIENCY 5 0.0005
300 HEPATITIS 13 0.0005
301 PROTHROMBIN TIME PROLONGED 3 0.0005
302 TRANSAMINASES INCREASED 11 0.0005
303 SUDDEN HEARING LOSS 1 0.0005
304 HEPATOCELLULAR INJURY 7 0.0005
305 LIBIDO INCREASED 1 0.0005
306 MUSCLE CONTRACTURE 1 0.0005
307 RENAL MASS 1 0.0005
308 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
309 PHYSICAL ASSAULT 1 0.0005
310 HYPOKALAEMIA 22 0.0005
311 HEPATIC NEOPLASM MALIGNANT 1 0.0005
312 PURULENT DISCHARGE 2 0.0005
313 PULMONARY TUBERCULOSIS 2 0.0005
314 BODY HEIGHT DECREASED 5 0.0005
315 PSEUDOMONAS INFECTION 4 0.0005
316 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
317 ENDOMETRIAL CANCER 1 0.0005
318 BLOOD CREATINE INCREASED 2 0.0005
319 ADENOCARCINOMA 1 0.0004
320 CHRONIC GASTRITIS 1 0.0004
321 TREATMENT NONCOMPLIANCE 24 0.0004
322 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
323 METASTASES TO LUNG 5 0.0004
324 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
325 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
326 ELECTROLYTE IMBALANCE 5 0.0004
327 BILIRUBIN CONJUGATED INCREASED 1 0.0004
328 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
329 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
330 WRONG DOSE 1 0.0004
331 HYPOKINESIA 6 0.0004
332 SKIN FRAGILITY 1 0.0004
333 JAUNDICE 11 0.0004
334 TRANSPLANT FAILURE 1 0.0004
335 HYPERPARATHYROIDISM SECONDARY 1 0.0004
336 OSTEITIS 1 0.0004
337 OSTEONECROSIS 13 0.0004
338 PATHOLOGICAL FRACTURE 2 0.0004
339 AMMONIA INCREASED 2 0.0004
340 ABDOMINAL INFECTION 1 0.0004
341 RENAL FAILURE CHRONIC 3 0.0004
342 BONE DISORDER 7 0.0004
343 ANKYLOSING SPONDYLITIS 5 0.0004
344 MUSCULAR WEAKNESS 43 0.0004
345 BLOOD ALBUMIN DECREASED 3 0.0004
346 MOVEMENT DISORDER 12 0.0004
347 BLOOD SODIUM INCREASED 1 0.0004
348 CHONDROPATHY 1 0.0004
349 FOOT FRACTURE 7 0.0004
350 RED BLOOD CELL COUNT INCREASED 1 0.0004
351 GASTRIC ULCER HAEMORRHAGE 2 0.0004
352 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
353 VENTRICULAR SEPTAL DEFECT 2 0.0003
354 MUSCULOSKELETAL DISCOMFORT 6 0.0003
355 GASTRIC HAEMORRHAGE 4 0.0003
356 MYOPATHY 3 0.0003
357 HERPES VIRUS INFECTION 2 0.0003
358 PARAPLEGIA 1 0.0003
359 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
360 PERITONITIS 7 0.0003
361 BLOOD CULTURE POSITIVE 1 0.0003
362 BLOOD BILIRUBIN INCREASED 9 0.0003
363 HEPATITIS CHOLESTATIC 2 0.0003
364 NOCTURIA 4 0.0003
365 NO THERAPEUTIC RESPONSE 4 0.0003
366 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
367 APPENDICITIS 3 0.0003
368 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
369 BLOOD CREATININE DECREASED 1 0.0003
370 MUSCLE ATROPHY 4 0.0003
371 GAIT DISTURBANCE 60 0.0003
372 CHROMATURIA 7 0.0003
373 PORTAL VEIN THROMBOSIS 1 0.0003
374 POSTURE ABNORMAL 1 0.0003
375 CYTOMEGALOVIRUS INFECTION 5 0.0003
376 VIRAL INFECTION 10 0.0003
377 PLANTAR FASCIITIS 1 0.0003
378 DIABETIC RETINOPATHY 1 0.0003
379 AUTOIMMUNE HEPATITIS 2 0.0003
380 HEART DISEASE CONGENITAL 1 0.0003
381 FIBRIN D DIMER INCREASED 1 0.0003
382 BREAST PAIN 3 0.0003
383 METASTASIS 2 0.0003
384 DERMATITIS BULLOUS 2 0.0003
385 RASH PUSTULAR 2 0.0003
386 PROTEIN TOTAL DECREASED 1 0.0003
387 AUTOIMMUNE THYROIDITIS 1 0.0003
388 CHEMOTHERAPY 1 0.0003
389 GASTRIC ULCER 5 0.0003
390 THYROID MASS 1 0.0003
391 PELVIC FRACTURE 2 0.0003
392 CERVIX CARCINOMA 1 0.0003
393 PNEUMONIA FUNGAL 1 0.0003
394 POLYDIPSIA 1 0.0003
395 TRANSPLANT REJECTION 2 0.0002
396 BONE MARROW FAILURE 5 0.0002
397 ASPHYXIA 2 0.0002
398 ANAPHYLACTOID REACTION 1 0.0002
399 SPINAL COMPRESSION FRACTURE 2 0.0002
400 THYROID FUNCTION TEST ABNORMAL 1 0.0002
401 NEPHROLITHIASIS 11 0.0002
402 RHABDOMYOLYSIS 10 0.0002
403 LIVE BIRTH 2 0.0002
404 INTESTINAL STENOSIS 1 0.0002
405 MUSCLE FATIGUE 1 0.0002
406 LUNG NEOPLASM 1 0.0002
407 HAEMATURIA 8 0.0002
408 BLOOD POTASSIUM DECREASED 7 0.0002
409 METASTATIC NEOPLASM 1 0.0002
410 MYOSITIS 2 0.0002
411 URINARY TRACT DISORDER 1 0.0002
412 URINE ABNORMALITY 1 0.0002
413 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
414 LUMBAR VERTEBRAL FRACTURE 1 0.0002
415 SHOCK 5 0.0002
416 FLANK PAIN 2 0.0002
417 ABORTION INDUCED 2 0.0002
418 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
419 PRODUCT PACKAGING ISSUE 2 0.0002
420 MUSCULOSKELETAL DISORDER 4 0.0002
421 ACUTE RESPIRATORY FAILURE 4 0.0002
422 GUILLAIN-BARRE SYNDROME 1 0.0002
423 RENAL CELL CARCINOMA 1 0.0002
424 RENAL TUBULAR NECROSIS 2 0.0002
425 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
426 PULMONARY MASS 3 0.0002
427 ARTHRALGIA 83 0.0002
428 INITIAL INSOMNIA 2 0.0002
429 FOETAL DEATH 1 0.0002
430 DRUG-INDUCED LIVER INJURY 6 0.0002
431 MOUTH ULCERATION 4 0.0002
432 POLYARTHRITIS 1 0.0002
433 OSTEOARTHRITIS 8 0.0002
434 MYALGIA 32 0.0002
435 ANAL FISTULA 1 0.0002
436 POOR QUALITY SLEEP 4 0.0002
437 DECREASED ACTIVITY 2 0.0002
438 STRESS FRACTURE 1 0.0002
439 CHRONIC KIDNEY DISEASE 14 0.0002
440 METASTASES TO BONE 3 0.0002
441 BACK PAIN 42 0.0002
442 RENAL FAILURE 24 0.0002
443 NECROSIS 1 0.0002
444 BLOOD UREA INCREASED 3 0.0002
445 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
446 CORONARY ARTERY BYPASS 1 0.0002
447 EXERCISE TOLERANCE DECREASED 1 0.0002
448 RENAL DISORDER 8 0.0002
449 HYPERTRIGLYCERIDAEMIA 1 0.0002
450 GALLBLADDER DISORDER 3 0.0002
451 CARDIAC PACEMAKER INSERTION 1 0.0002
452 THYROID CANCER 2 0.0002
453 PELVIC PAIN 3 0.0002
454 INGUINAL HERNIA 1 0.0002
455 FEMUR FRACTURE 5 0.0002
456 SCOLIOSIS 1 0.0002
457 OLIGURIA 1 0.0002
458 HEPATIC STEATOSIS 3 0.0002
459 INFECTION 23 0.0002
460 HYPOCALCAEMIA 3 0.0002
461 ENTERITIS 1 0.0002
462 PROCTALGIA 1 0.0002
463 ANOREXIA 2 0.0002
464 HERPES SIMPLEX 1 0.0002
465 NODULE 2 0.0002
466 SPINAL FRACTURE 3 0.0001
467 CHOLECYSTITIS CHRONIC 1 0.0001
468 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
469 POST-TRAUMATIC STRESS DISORDER 1 0.0001
470 METASTASES TO LYMPH NODES 1 0.0001
471 NEPHROTIC SYNDROME 1 0.0001
472 EXPOSURE DURING PREGNANCY 9 0.0001
473 ROAD TRAFFIC ACCIDENT 6 0.0001
474 BLOOD TEST ABNORMAL 2 0.0001
475 CONDITION AGGRAVATED 43 0.0001
476 PARALYSIS 2 0.0001
477 GRAFT VERSUS HOST DISEASE 1 0.0001
478 VISUAL FIELD DEFECT 1 0.0001
479 PRODUCT PRESCRIBING ISSUE 3 0.0001
480 SNEEZING 3 0.0001
481 MUSCULOSKELETAL PAIN 7 0.0001
482 HEPATIC ENZYME INCREASED 9 0.0001
483 THERAPEUTIC RESPONSE DECREASED 8 0.0001
484 BLOOD COUNT ABNORMAL 2 0.0001
485 TROPONIN INCREASED 1 0.0001
486 CHEST PAIN 24 0.0001
487 LUNG INFECTION 2 0.0001
488 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
489 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
490 TRICUSPID VALVE INCOMPETENCE 1 0.0001
491 ULCER 2 0.0001
492 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
493 MUSCLE TIGHTNESS 2 0.0001
494 POLYURIA 1 0.0001
495 CHOLELITHIASIS 4 0.0001
496 ABASIA 3 0.0001
497 TYPE 2 DIABETES MELLITUS 4 0.0001
498 HAEMATEMESIS 3 0.0001
499 LOCAL SWELLING 2 0.0001
500 URINE OUTPUT DECREASED 1 0.0001
501 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
502 HAEMOLYTIC ANAEMIA 1 0.0001
503 PNEUMONIA BACTERIAL 1 0.0001
504 RETINAL DETACHMENT 1 0.0001
505 OVARIAN CANCER 1 0.0001
506 BACTERIAL INFECTION 2 0.0001
507 ARTERIOSCLEROSIS 1 0.0001
508 SPINAL DISORDER 1 0.0001
509 NEUROPATHY PERIPHERAL 10 0.0001
510 POST PROCEDURAL COMPLICATION 2 0.0001
511 HYPERCHOLESTEROLAEMIA 1 0.0001
512 THROMBOTIC MICROANGIOPATHY 1 0.0001
513 DISABILITY 2 0.0001
514 LIGAMENT SPRAIN 1 0.0001
515 BLADDER DISORDER 1 0.0001
516 PREGNANCY 2 0.0001
517 EMPHYSEMA 1 0.0001
518 PERITONITIS BACTERIAL 1 0.0001
519 PRODUCT ADMINISTRATION ERROR 2 0.0001
520 SUBARACHNOID HAEMORRHAGE 1 0.0001
521 PAIN 60 0.0001
522 TEMPERATURE INTOLERANCE 1 0.0001
523 PETECHIAE 1 0.0001
524 ASTHENIA 36 0.0001
525 DRUG INEFFECTIVE 126 0.0001
526 LIVER FUNCTION TEST INCREASED 2 0.0001
527 RASH MACULO-PAPULAR 2 0.0001
528 PANCREATITIS ACUTE 2 0.0001
529 PRODUCT QUALITY ISSUE 12 0.0001
530 MITRAL VALVE INCOMPETENCE 1 0.0001
531 MYOCARDIAL ISCHAEMIA 1 0.0001
532 NEOPLASM 1 0.0001
533 EYELID OEDEMA 1 0.0001
534 LYMPHADENOPATHY 3 0.0001
535 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
536 DISEASE RECURRENCE 4 0.0001
537 PRODUCTIVE COUGH 4 0.0001
538 HYPERGLYCAEMIA 3 0.0001
539 PLEURAL EFFUSION 5 0.0001
540 ENCEPHALOPATHY 2 0.0001
541 CYST 1 0.0001
542 PEMPHIGUS 1 0.0001
543 INTENTIONAL PRODUCT MISUSE 7 0.0001
544 UNEVALUABLE EVENT 6 0.0001
545 PRODUCT COMPLAINT 2 0.0001
546 DIABETES MELLITUS 6 0.0001
547 PAIN IN EXTREMITY 23 0.0001
548 THERAPY CESSATION 4 0.0001
549 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
550 SKIN ULCER 2 0.0001
551 PLASMA CELL MYELOMA 3 0.0001
552 ABDOMINAL DISTENSION 8 0.0001
553 ABORTION SPONTANEOUS 3 0.0001
554 PRODUCT TASTE ABNORMAL 1 0.0001
555 OEDEMA 4 0.0001
556 PNEUMONITIS 2 0.0001
557 WITHDRAWAL SYNDROME 3 0.0001
558 SINUS TACHYCARDIA 1 0.0001
559 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
560 MOBILITY DECREASED 5 0.0001
561 PANCREATIC CARCINOMA 2 0.0001
562 MYELODYSPLASTIC SYNDROME 1 0.0001
563 HYPERTHYROIDISM 1 0.0001
564 LIVER FUNCTION TEST ABNORMAL 2 0.0001
565 APATHY 1 0.0001
566 ABDOMINAL PAIN UPPER 14 0.0001
567 IMMUNODEFICIENCY 1 0.0001
568 PLATELET COUNT DECREASED 7 0.0001
569 DISCOMFORT 4 0.0001
570 DRUG DISPENSING ERROR 1 0.0001
571 HOSPITALISATION 10 0.0001
572 LIMB DISCOMFORT 2 0.0001
573 ACUTE MYELOID LEUKAEMIA 1 0.0001
574 LACTIC ACIDOSIS 2 0.0001
575 DRUG LEVEL INCREASED 1 0.0001
576 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
577 MULTI-ORGAN FAILURE 1 0.0001
578 OEDEMA PERIPHERAL 7 0.0001
579 WEIGHT DECREASED 16 0.0001
580 DEPRESSED MOOD 3 0.0001
581 DRUG INTERACTION 9 0.0001
582 LYMPHOCYTE COUNT DECREASED 1 0.0001
583 TOOTHACHE 1 0.0001
584 SWELLING 5 0.0001
585 BLISTER 3 0.0001
586 INTESTINAL OBSTRUCTION 2 0.0001
587 FLATULENCE 3 0.0001
588 LETHARGY 3 0.0001
589 PULMONARY FIBROSIS 1 0.0001
590 ERUCTATION 1 0.0001
591 DECREASED APPETITE 12 0.0001
592 EAR PAIN 1 0.0001
593 PRESCRIBED UNDERDOSE 1 0.0001
594 PRODUCT PHYSICAL ISSUE 1 0.0000
595 DYSKINESIA 2 0.0000
596 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
597 NASOPHARYNGITIS 9 0.0000
598 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
599 HYPOAESTHESIA 7 0.0000
600 RECTAL HAEMORRHAGE 2 0.0000
601 SKIN CANCER 1 0.0000
602 MENTAL DISORDER 2 0.0000
603 MUSCULOSKELETAL STIFFNESS 4 0.0000
604 MELAENA 1 0.0000
605 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
606 NEOPLASM MALIGNANT 3 0.0000
607 THROMBOCYTOPENIA 5 0.0000
608 PRODUCT AVAILABILITY ISSUE 1 0.0000
609 COUGH 12 0.0000
610 COMA 2 0.0000
611 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
612 LEUKOPENIA 2 0.0000
613 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
614 CHEST DISCOMFORT 4 0.0000
615 ERECTILE DYSFUNCTION 1 0.0000
616 HAEMATOMA 1 0.0000
617 DEAFNESS 1 0.0000
618 ARTHRITIS 3 0.0000
619 LIMB INJURY 1 0.0000
620 ABNORMAL DREAMS 1 0.0000
621 DEMENTIA 1 0.0000
622 RED BLOOD CELL COUNT DECREASED 1 0.0000
623 ANGINA PECTORIS 1 0.0000
624 FATIGUE 27 0.0000
625 DYSSTASIA 1 0.0000
626 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
627 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
628 CONTUSION 3 0.0000
629 ALOPECIA 6 0.0000
630 VISUAL ACUITY REDUCED 1 0.0000
631 FUNGAL INFECTION 1 0.0000
632 GAIT INABILITY 1 0.0000
633 ABDOMINAL DISCOMFORT 5 0.0000
634 PYREXIA 10 0.0000
635 RASH MACULAR 1 0.0000
636 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
637 C-REACTIVE PROTEIN INCREASED 1 0.0000
638 PANIC ATTACK 1 0.0000
639 DYSURIA 1 0.0000
640 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
641 DISEASE PROGRESSION 3 0.0000
642 DISORIENTATION 1 0.0000
643 JOINT SWELLING 3 0.0000
644 NEUTROPHIL COUNT DECREASED 1 0.0000
645 POLLAKIURIA 1 0.0000
646 RENAL FAILURE ACUTE 1 0.0000
647 LOSS OF CONSCIOUSNESS 3 0.0000
648 SEPTIC SHOCK 1 0.0000
649 OFF LABEL USE 20 0.0000
650 MALAISE 10 0.0000
651 LIVER DISORDER 1 0.0000
652 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
653 THERAPY NON-RESPONDER 1 0.0000
654 NO ADVERSE EVENT 4 0.0000
655 SKIN DISCOLOURATION 1 0.0000
656 OROPHARYNGEAL PAIN 2 0.0000
657 BREAST CANCER 2 0.0000
658 COGNITIVE DISORDER 1 0.0000
659 PRODUCT USE ISSUE 4 0.0000
660 ARRHYTHMIA 1 0.0000
661 PULMONARY EMBOLISM 2 0.0000
662 MULTIPLE SCLEROSIS 1 0.0000
663 FEELING ABNORMAL 5 0.0000
664 DRUG INTOLERANCE 2 0.0000
665 INTERSTITIAL LUNG DISEASE 1 0.0000
666 HYPOGLYCAEMIA 1 0.0000
667 DIARRHOEA 13 0.0000
668 DRY EYE 1 0.0000
669 CELLULITIS 1 0.0000
670 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
671 HAEMOGLOBIN DECREASED 2 0.0000
672 PANCREATITIS 1 0.0000
673 HYPERTENSION 4 0.0000
674 DEATH 16 0.0000
675 DISTURBANCE IN ATTENTION 1 0.0000
676 OVERDOSE 4 0.0000
677 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
678 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
679 FALL 6 0.0000
680 PANCYTOPENIA 1 0.0000
681 PRODUCT SUBSTITUTION ISSUE 1 0.0000
682 DYSPHONIA 1 0.0000
683 PALPITATIONS 2 0.0000
684 SURGERY 1 0.0000
685 NASAL CONGESTION 1 0.0000
686 VERTIGO 1 0.0000
687 DYSPNOEA 9 0.0000
688 AMNESIA 1 0.0000
689 FEBRILE NEUTROPENIA 1 0.0000
690 BLOOD PRESSURE DECREASED 1 0.0000
691 INSOMNIA 4 0.0000
692 VISION BLURRED 2 0.0000
693 INJURY 1 0.0000
694 SLEEP DISORDER 1 0.0000
695 THERAPY INTERRUPTED 1 0.0000
696 RASH 6 0.0000
697 RESPIRATORY FAILURE 1 0.0000
698 EPISTAXIS 1 0.0000
699 ACUTE KIDNEY INJURY 2 0.0000
700 ABDOMINAL PAIN 3 0.0000
701 THROMBOSIS 1 0.0000
702 PNEUMONIA 4 0.0000
703 DRY MOUTH 1 0.0000
704 CEREBROVASCULAR ACCIDENT 2 0.0000
705 MYOCARDIAL INFARCTION 2 0.0000
706 TACHYCARDIA 1 0.0000
707 GASTROINTESTINAL DISORDER 1 0.0000
708 ADVERSE DRUG REACTION 1 0.0000
709 MUSCLE SPASMS 2 0.0000
710 VOMITING 5 0.0000
711 ATRIAL FIBRILLATION 1 0.0000
712 DYSPEPSIA 1 0.0000
713 SYNCOPE 1 0.0000
714 HAEMORRHAGE 1 0.0000
715 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
716 CHILLS 1 0.0000
717 DIZZINESS 4 0.0000
718 HEADACHE 5 0.0000
719 NAUSEA 6 0.0000
720 PARAESTHESIA 1 0.0000
721 DRUG DEPENDENCE 1 0.0000
722 URTICARIA 1 0.0000
723 URINARY TRACT INFECTION 1 0.0000
724 ANAEMIA 1 0.0000
725 PRURITUS 2 0.0000
726 HYPOTENSION 1 0.0000
727 CONSTIPATION 1 0.0000
728 DEPRESSION 1 0.0000
729 INCORRECT DOSE ADMINISTERED 1 0.0000